Abologix - Model JAM-C - Junction Adhesion Molecule C Antibodies for Cancer Patients - Brochure

Junction Adhesion Molecule C (JAM-C) has been studied at the laboratories of Prof. Beat Imhof and Prof. Thomas Matthes at the Université de Genève for over 10+ years (36 peer reviewed publications). There is in addition 60+ publications from other laboratories. JAM-C is expressed by certain lymphocytes and prominently localises to tight junctions of endotelial cells. In many lymphoma cells, JAM-C is expressed.